Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Scott Zashin, MD - Treatment of Sjogren's Syndrome with LDN (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint

Samyadev Datta, MD - Pharmacology of Low dose Naltrexone in Chronic Pain Management (2019 Conference) (LDN, low dose naltrexone)

Samyadev Datta, MD discusses LDN and ultra-low dose naltrexone (ULDN) to treat chronic pain and inflammatory/autoimmune conditions. He presents on the history and pharmacology of naltrexone, forms in which LDN can be prepared. Several case studies on pain are presented

Paul Battle, PA-C - Autoimmune Hepatitis (2019 Conference) (LDN, low dose naltrexone)

Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)

Nasha Winters, ND - Quelling the side effects of immune therapies with LDN (2019 Conference) (LDN, low dose naltrexone)

Mark Cooper, PhD - LDN, Endosomes and the Nanophysilogy of Autoimmune Movement Disorders II (2019 Conference) (LDN, low dose naltrexone)

Mark Cooper, PhD - LDN, Endosomes and the Nanophysilogy of Autoimmune Movement Disorders I (2019 Conference) (LDN, low dose naltrexone)